{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:43:13Z","timestamp":1785786193928,"version":"3.56.0"},"reference-count":138,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cutaneous malignancies represent the most common cancers worldwide and pose a growing public health burden. While surgical excision remains the primary curative modality, radiotherapy offers an effective adjuvant therapy for high-risk histopathologic features and an established, organ-preserving alternative for patients with inoperable disease or lesions in cosmetically or functionally sensitive sites. Advances in radiotherapeutic techniques, including brachytherapy and proton therapy, have expanded the therapeutic armamentarium, allowing tailored treatment based on tumor depth, extent, and anatomical location. Contemporary evidence highlights favorable local control and toxicity outcomes with modern radiation therapy approaches, yet data remain fragmented, with most studies limited by small cohorts, heterogeneous methodologies, and limited follow-up durations. Furthermore, the role of radiotherapy in complex scenarios, such as perineural invasion, recurrent disease, and previously irradiated fields, continues to evolve. This review synthesizes the current literature on radiotherapeutic management of skin cancer, critically evaluates dosimetric and clinical outcomes across modalities, and identifies key gaps in evidence. Emphasis is placed on the need for prospective, multicenter investigations to better define comparative effectiveness, optimize dose-fractionation regimens, and integrate emerging technologies into clinical practice. Radiotherapy remains an indispensable modality in dermatological oncology, offering curative potential with preservation of cosmesis and function, yet its optimal utilization demands further high-quality research to refine patient selection and therapeutic strategies.<\/jats:p>","DOI":"10.3390\/jcm14186547","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:12:44Z","timestamp":1758121964000},"page":"6547","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiotherapeutic Modalities and Advancements in the Treatment of Cutaneous Malignancies"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5590-8135","authenticated-orcid":false,"given":"Noor","family":"Malik","sequence":"first","affiliation":[{"name":"School of Medicine and Dentistry, University of Lancashire, Preston PR1 2HE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5589-0782","authenticated-orcid":false,"given":"Irini","family":"Yacoub","sequence":"additional","affiliation":[{"name":"New York Proton Center, New York, NY 10035, USA"},{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-473X","authenticated-orcid":false,"given":"Kristin","family":"Hsieh","sequence":"additional","affiliation":[{"name":"New York Proton Center, New York, NY 10035, USA"},{"name":"Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Isabelle","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Chhabra","sequence":"additional","affiliation":[{"name":"New York Proton Center, New York, NY 10035, USA"},{"name":"Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-3694","authenticated-orcid":false,"suffix":"2nd","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[{"name":"New York Proton Center, New York, NY 10035, USA"},{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"ref_1","unstructured":"International Agency for Research on Cancer (2025, September 10). Skin Cancer. Available online: https:\/\/www.iarc.who.int\/cancer-type\/skin-cancer\/."},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CM9.0000000000003416","article-title":"Recent global patterns in skin cancer incidence, mortality, and prevalence","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hu, W., Fang, L., Ni, R., Zhang, H., and Pan, G. (2022). Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09940-3"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin cancer: Epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol. Ther."},{"key":"ref_6","unstructured":"Kim, J.Y., and Dao, H. (2023). Physiology, Integument. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_7","unstructured":"National Cancer Institute (2025, June 21). Cancer Stat Facts: Melanoma of the Skin. SEER Cancer Statistics, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cancers3010126","article-title":"Decoding melanoma metastasis","volume":"3","author":"Damsky","year":"2010","journal-title":"Cancers"},{"key":"ref_9","unstructured":"American Cancer Society (2025, June 21). Key Statistics for Melanoma Skin Cancer. Available online: https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/about\/key-statistics.html."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","article-title":"United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019","volume":"85","author":"Aggarwal","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","unstructured":"Hadian, Y., Howell, J.Y., Ramsey, M.L., and Buckley, C. (2025, June 25). Cutaneous Squamous Cell Carcinoma, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441939\/."},{"key":"ref_12","unstructured":"McDaniel, B., and Steele, R.B. (2025, June 25). Basal Cell Carcinoma, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482439\/."},{"key":"ref_13","unstructured":"Brady, M., and Puckett, Y. (2025, September 10). Merkel Cell Carcinoma of the Skin, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482329\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0094-1298(20)32291-4","article-title":"Squamous Cell and Adnexal Carcinomas of the Skin","volume":"24","author":"Roth","year":"1997","journal-title":"Clin. Plast. Surg."},{"key":"ref_15","unstructured":"Prickett, K.A., and Ramsey, M.L. (2025, June 26). Mohs micrographic surgery, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441833\/."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"adv00084","DOI":"10.2340\/00015555-3441","article-title":"Incomplete excision of cutaneous squamous cell carcinoma; systematic review of the literature","volume":"100","author":"Genders","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_17","unstructured":"National Comprehensive Cancer Network (2025). Squamous Cell Skin Cancer, Version 2.2025. NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/squamous.pdf."},{"key":"ref_18","unstructured":"National Comprehensive Cancer Network (2025). Cutaneous Melanoma, Version 2.2025. NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf."},{"key":"ref_19","unstructured":"National Comprehensive Cancer Network (2025). Non-Melanoma Skin Cancer, Version 2.2025. NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nmsc.pdf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00403-021-02204-3","article-title":"Complex skin cancer treatment requiring reconstructive plastic surgery: An interview study on the experiences and needs of patients","volume":"314","author":"Wakkee","year":"2022","journal-title":"Arch. Dermatol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/jdv.17467","article-title":"Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas","volume":"35","author":"Grob","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113251","DOI":"10.1016\/j.ejca.2023.113251","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention\u2014Update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5603\/RPOR.a2021.0013","article-title":"A small case series about safety and effectiveness of a hypofractionated electron beam radiotherapy schedule in five fractions for facial non-melanoma skin cancer among frail and elderly patients","volume":"26","author":"Ferini","year":"2021","journal-title":"Rep. Pr. Oncol. Radiother."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Yosefof, E., Kurman, N., and Yaniv, D. (2023). The role of radiation therapy in the treatment of non-melanoma skin cancer. Cancers, 15.","DOI":"10.3390\/cancers15092408"},{"key":"ref_25","unstructured":"National Comprehensive Cancer Network (2025). Merkel Cell Carcinoma, Version 2.2025. NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mcc.pdf."},{"key":"ref_26","unstructured":"National Comprehensive Cancer Network (2025). Primary Cutaneous Lymphomas, Version 3.2025. NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/primary_cutaneous.pdf."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prro.2019.10.014","article-title":"Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: Executive summary of an American Society for Radiation Oncology clinical practice guideline","volume":"10","author":"Likhacheva","year":"2020","journal-title":"Pract. Radia.t Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","article-title":"GEC-ESTRO ACROP recommendations in skin brachytherapy","volume":"126","author":"Guinot","year":"2018","journal-title":"Radiother Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, and National Cancer Institute (2009). Common Terminology Criteria for Adverse Events (CTCAE), NIH. Version 4.0."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.det.2016.02.011","article-title":"Practice and educational gaps in radiation therapy in dermatology","volume":"34","author":"Cognetta","year":"2016","journal-title":"Dermatol. Clin."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1002\/der2.229","article-title":"Superficial radiation therapy in dermatology: A historical perspective","volume":"5","author":"Bhupalam","year":"2024","journal-title":"Dermatol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1120\/jacmp.v16i5.5407","article-title":"Optimum radiation source for radiation therapy of skin cancer","volume":"16","author":"Safigholi","year":"2015","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_34","first-page":"12","article-title":"Consensus guidelines on the use of superficial radiation therapy for treating nonmelanoma skin cancers and keloids","volume":"12","author":"Nestor","year":"2019","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_35","unstructured":"Velindre University NHS Trust (2025, July 07). Clinical Protocol: Skin Malignancies. Issue 5. Available online: https:\/\/velindre.nhs.wales\/about-us\/publications\/freedom-of-information\/foia-disclosure-logs-2023\/january-2023\/corp-2023-010-skin-cancer-pathway-management-attachment-2\/."},{"key":"ref_36","first-page":"e174","article-title":"Superficial radiation therapy for nonmelanoma skin cancer: A review","volume":"13","author":"Han","year":"2023","journal-title":"Dermatol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaad.2012.06.001","article-title":"Superficial X-ray in the treatment of basal and squamous cell carcinomas: A viable option in select patients","volume":"67","author":"Cognetta","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2005.07.045","article-title":"Soft X-ray therapy for cutaneous basal cell and squamous cell carcinomas","volume":"53","author":"Schulte","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e13926","DOI":"10.1002\/acm2.13926","article-title":"Implementation of superficial radiation therapy (SRT) using SRT-100 Vision\u2122 for non-melanoma skin cancer in a Radiation Oncology clinic","volume":"24","author":"Lee","year":"2023","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Moloney, M., Harris, P.M., Kaczmarski, P., Zheng, S., Ladd, D., Serure, D., Malik, A., and Yu, L. (2025). Updated results of 3,050 non-melanoma skin cancer (NMSC) lesions in 1,725 patients treated with high resolution dermal ultrasound-guided superficial radiotherapy, a multi-institutional study. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-13864-z"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1007\/s00432-023-04597-2","article-title":"Analysis of image-guided superficial radiation therapy (IGSRT) on the treatment of early-stage non-melanoma skin cancer (NMSC) in the outpatient dermatology setting","volume":"149","author":"Tran","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","article-title":"Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides)","volume":"40","author":"Wilson","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1748-717X-7-171","article-title":"Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma","volume":"7","author":"Kang","year":"2012","journal-title":"Radiat. Oncol."},{"key":"ref_44","unstructured":"Plastic Surgery Key (2025, July 11). Radiotherapy. Available online: https:\/\/plasticsurgerykey.com\/radiotherapy-2\/."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0360-3016(92)90650-7","article-title":"Radiation therapy for skin cancer near the eye: Kilovoltage X-rays versus electrons","volume":"23","author":"Amdur","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1158\/0008-5472.CAN-22-0656","article-title":"Orthovoltage X-rays exhibit increased efficacy compared with \u03b3-rays in preclinical irradiation","volume":"82","author":"Bell","year":"2022","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0167-8140(89)90055-8","article-title":"Radiation therapy of skin carcinomas: Results of a hypofractionated irradiation schedule in 675 cases followed more than 2 years","volume":"14","author":"Abbatucci","year":"1989","journal-title":"Radiother. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Marconi, D., Resende, B., Rauber, E., Soares, P., Fernandes, J., Carvalho, A., Kupelian, P., and Chen, A. (2014). Head and neck nonmelanoma skin cancer treated by orthovoltage radiation: An analysis of 1021 cases. Int. J. Radiat. Oncol. Biol. Phys., 90.","DOI":"10.1016\/j.ijrobp.2014.05.1725"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13014-020-01615-2","article-title":"Radiotherapy for lentigo maligna and lentigo maligna melanoma\u2014A systematic review","volume":"15","author":"Hendrickx","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1067\/mjd.2000.106241","article-title":"Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients","volume":"43","author":"Brunner","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijrobp.2013.06.2061","article-title":"Patient-reported outcomes in patients with nonmelanomatous skin cancers of the face treated with orthovoltage radiation therapy: A cross-sectional survey","volume":"87","author":"Kharofa","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jaad.2024.01.010","article-title":"Superficial X-ray in the treatment of nonaggressive basal and squamous cell carcinoma in the elderly: A 22-year retrospective analysis","volume":"90","author":"Mattia","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"AB90","DOI":"10.1016\/j.jaad.2023.07.363","article-title":"Superficial X-ray in the treatment of basal and squamous cell carcinomas for select patients: The second decade","volume":"89","author":"Green","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/lary.25865","article-title":"Orthovoltage for basal cell carcinoma of the head and neck: Excellent local control and low toxicity profile","volume":"126","author":"Duinkerken","year":"2016","journal-title":"Laryngoscope"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjophthalmol-2012-302991","article-title":"Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma","volume":"97","author":"Krema","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/cncr.11798","article-title":"Superficial radiotherapy for patients with basal cell carcinoma: Recurrence rates, histologic subtypes, and expression of p53 and Bcl-2","volume":"98","author":"Zagrodnik","year":"2003","journal-title":"Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1053-4296(99)80056-3","article-title":"Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems","volume":"9","author":"Verhey","year":"1999","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3857\/roj.2018.00122","article-title":"Intensity-modulated radiation therapy: A review with a physics perspective","volume":"36","author":"Cho","year":"2018","journal-title":"Radiat. Oncol. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3857\/roj.2015.01592","article-title":"Dosimetric comparison of axilla and groin radiotherapy techniques for high-risk and locally advanced skin cancer","volume":"34","author":"Mattes","year":"2016","journal-title":"Radiat. Oncol. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1470-2045(15)00187-4","article-title":"Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02\/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial","volume":"16","author":"Henderson","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Cheung, K.Y. (2006). Intensity modulated radiotherapy: Advantages, limitations and future developments. Biomed. Imaging Interv. J., 2.","DOI":"10.2349\/biij.2.1.e19"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/sj.bjc.6602577","article-title":"Intensity-modulated radiation therapy: Emerging cancer treatment technology","volume":"92","author":"Hong","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0360-3016(02)03940-8","article-title":"Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer","volume":"55","author":"Chao","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0360-3016(99)00550-7","article-title":"Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer","volume":"46","author":"Dawson","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1754-9485.2011.02277.x","article-title":"The role of radiotherapy for T4 non-melanoma skin carcinoma","volume":"55","author":"Matthiesen","year":"2011","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.prro.2012.06.003","article-title":"Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck","volume":"3","author":"Hallemeier","year":"2013","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_67","first-page":"542","article-title":"Post-mastectomy radiotherapy: Impact of bolus thickness and irradiation technique on skin dose","volume":"34","author":"Pitteloud","year":"2023","journal-title":"Z. Med. Phys."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.clon.2009.08.002","article-title":"Integral dose in three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy","volume":"21","author":"Yang","year":"2009","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1118\/1.4908224","article-title":"Optimization approaches to volumetric modulated arc therapy planning","volume":"42","author":"Unkelbach","year":"2015","journal-title":"Med. Phys."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.30699\/mci.5.4.522-1","article-title":"Clinical differences among volumetric modulated arc therapy, intensity modulated radiation therapy, and 3D conformal radiation therapy in prostate cancer: A brief review study","volume":"5","author":"Afrin","year":"2021","journal-title":"Multidiscip. Cancer Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-8-26","article-title":"Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: A planning study","volume":"8","author":"Holt","year":"2013","journal-title":"Radiat. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13555-016-0120-y","article-title":"Acute and chronic cutaneous reactions to ionizing radiation therapy","volume":"6","author":"Bray","year":"2016","journal-title":"Dermatol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"103739","DOI":"10.1016\/j.clon.2024.103739","article-title":"Outcomes with radiation therapy as primary treatment for unresectable cutaneous head and neck squamous cell carcinoma","volume":"38","author":"Zhang","year":"2025","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2023.09.030","article-title":"Definitive radiation therapy for inoperable stage III\/IV cutaneous squamous cell carcinoma: A single-institution retrospective cohort study","volume":"90","author":"Granger","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000521067","article-title":"Radiotherapy, utilizing volumetric modulated arc therapy, for extensive skin field cancerization: A retrospective case series assessing efficacy, safety, and cosmetic outcomes at 12 months after treatment","volume":"14","author":"Spelman","year":"2022","journal-title":"Case Rep. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"849","DOI":"10.21873\/invivo.13510","article-title":"Effect of jaw tracking during volumetric modulated arc therapy for facial non-melanoma skin cancer","volume":"38","author":"Park","year":"2024","journal-title":"Vivo"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101798","DOI":"10.1016\/j.adro.2025.101798","article-title":"Optimizing breast cancer radiation therapy with volumetric modulated arc therapy and skin flash: A case study using deep inspiration breath hold and Cherenkov imaging","volume":"10","author":"Robinson","year":"2025","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e14365","DOI":"10.1002\/acm2.14365","article-title":"Minimizing normal tissue low dose bath for left breast volumetric modulated arc therapy (VMAT) using jaw offset","volume":"25","author":"Zhang","year":"2024","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: A review of current literature and clinical use in practice","volume":"84","author":"Teoh","year":"2011","journal-title":"Br. J. Radiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/0971-6203.71763","article-title":"Electron beam characteristics at extended source-to-surface distances for irregular cut-outs","volume":"35","author":"Arunkumar","year":"2010","journal-title":"J. Med. Phys."},{"key":"ref_81","first-page":"114","article-title":"Electron beam therapy of primary tumors of the skin","volume":"80","author":"Reisner","year":"1990","journal-title":"Radiol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2020.06.021","article-title":"Essentials of depth dose calculations for clinical oncologists","volume":"33","author":"Mott","year":"2021","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100487","DOI":"10.1016\/j.phro.2023.100487","article-title":"Early clinical experience with a degraded 4 MeV electron beam in radiotherapy of superficial basal cell carcinoma","volume":"27","author":"Valve","year":"2023","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0958-3947(92)90023-9","article-title":"Dosimetry of small field electron beams","volume":"17","author":"Rustgi","year":"1992","journal-title":"Med. Dosim."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.canrad.2024.07.013","article-title":"Electron radiation therapy: Back to the future?","volume":"28","author":"Renard","year":"2024","journal-title":"Cancer Radiother."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hed.2880140305","article-title":"Electron beam therapy for skin cancer of the head and neck","volume":"14","author":"Zablow","year":"1992","journal-title":"Head Neck"},{"key":"ref_87","first-page":"77","article-title":"Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule","volume":"33","author":"Smits","year":"2022","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5114\/jcb.2024.144703","article-title":"Surface mold brachytherapy for head and neck non-melanoma skin cancer\u2014Local control rates and survival: A retrospective analysis","volume":"16","author":"Esmati","year":"2024","journal-title":"J. Contemp. Brachyther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5114\/jcb.2023.127837","article-title":"Multilayer intensity modulated contact interventional radiotherapy (brachytherapy): Stretching the therapeutic window in skin cancer","volume":"15","author":"Fionda","year":"2023","journal-title":"J. Contemp. Brachyther."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Benkhaled, S., Van Gestel, D., Cauduro, C.G.S., Palumbo, S., del Marmol, V., and Desmet, A. (2022). The state of the art of radiotherapy for non-melanoma skin cancer: A review of the literature. Front. Med., 9.","DOI":"10.3389\/fmed.2022.913269"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.brachy.2020.04.004","article-title":"The American Brachytherapy Society consensus statement for skin brachytherapy","volume":"19","author":"Shah","year":"2020","journal-title":"Brachytherapy"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5114\/jcb.2014.43247","article-title":"Non-melanoma skin cancer treated with HDR Valencia applicator: Clinical outcomes","volume":"6","author":"Tormo","year":"2014","journal-title":"J. Contemp. Brachyther."},{"key":"ref_93","first-page":"170","article-title":"The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator)","volume":"175","author":"Prager","year":"1999","journal-title":"Strahlenther. Onkol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5114\/jcb.2015.55746","article-title":"Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: A retrospective case series","volume":"7","author":"Delishaj","year":"2015","journal-title":"J. Contemp. Brachyther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.radonc.2017.12.029","article-title":"Skin cancer brachytherapy vs external beam radiation therapy (SCRiBE) meta-analysis","volume":"126","author":"Zaorsky","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5114\/jcb.2022.114661","article-title":"High-dose-rate skin brachytherapy with interstitial, surface, or a combination of interstitial and surface mold technique","volume":"14","author":"Brovchuk","year":"2022","journal-title":"J. Contemp. Brachyther."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Ciurlia, E., Santo, B., Barba, M.C., Cavalera, E., De Franco, P., De Matteis, S., Di Paola, G., Leone, A., Papaleo, A., and Rubini, D. (2025). Non-melanoma skin cancer treated with hypofractionated 192\u2013Ir contact brachytherapy: A single institution series. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1525926"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Monge-Cadet, J., Vairel, B., Morisseau, M., Moyal, E., Ducassou, A., Chira, C., Pag\u00e8s, C., Sibaud, V., Brun, T., and Modesto, A. (2024). High-dose-rate brachytherapy for treatment of facial skin cancers: Local control, toxicity, and quality of life in 67 patients. Cancers, 16.","DOI":"10.3390\/cancers16152742"},{"key":"ref_99","first-page":"e53067","article-title":"Treatment of basal cell carcinoma of the lower eyelid with high-dose-rate brachytherapy","volume":"16","author":"Oliveira","year":"2024","journal-title":"Cureus"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Bilski, M., Cisek, P., Baranowska, I., Kordzi\u0144ska-Cisek, I., Komaniecka, N., Hymos, A., Grywalska, E., and Nied\u017awiedzka-Rystwej, P. (2022). Brachytherapy in the treatment of non-melanoma skin peri-auricular cancers\u2014A retrospective analysis of a single institution experience. Cancers, 14.","DOI":"10.3390\/cancers14225614"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.brachy.2021.01.009","article-title":"High-dose-rate brachytherapy for facial skin cancer: Outcome and toxicity assessment for 71 cases","volume":"20","author":"Renard","year":"2021","journal-title":"Brachytherapy"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Virbel, G., Ka, K., Escande, A., Mortier, L., Barthoulot, M., Liem, X., Mirabel, X., Lartigau, E.F., and Cordoba, A. (2025). HDR and PDR brachytherapy for facial nonmelanoma skin cancer: Outcome and toxicity assessment for 155 patients. Brachytherapy, epub ahead of print.","DOI":"10.1016\/j.brachy.2025.06.011"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1748-717X-5-87","article-title":"The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer","volume":"5","author":"Bhatnagar","year":"2010","journal-title":"Radiat. Oncol."},{"key":"ref_104","unstructured":"Elekta AB\u2013Nucletron (2025, July 01). Esteya\u00ae Electronic Brachytherapy System. Stockholm, Sweden. Available online: http:\/\/www.esteya.com."},{"key":"ref_105","unstructured":"Elekta Xoft (2025, July 01). Xoft\u00ae Axxent\u00ae Electronic Brachytherapy System. Nashua, NH, USA. Available online: https:\/\/www.elekta.com\/products\/brachytherapy\/xoft\/."},{"key":"ref_106","unstructured":"Carl Zeiss Meditec AG (2025, July 01). INTRABEAM\u00ae Electronic Brachytherapy System. Jena, Germany. Available online: https:\/\/www.zeiss.com\/meditec\/en\/products\/intrabeam-700.html."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"20150002","DOI":"10.1259\/bjr.20150002","article-title":"Electronic brachytherapy\u2014Current status and future directions","volume":"88","author":"Eaton","year":"2015","journal-title":"Br. J. Radiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.brachy.2012.08.003","article-title":"Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year","volume":"12","author":"Bhatnagar","year":"2013","journal-title":"Brachytherapy"},{"key":"ref_109","first-page":"45","article-title":"Dosimetric characteristics of a new unit for electronic skin brachytherapy","volume":"6","author":"Chan","year":"2014","journal-title":"J. Contemp. Brachyther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5114\/jcb.2024.146795","article-title":"The Elekta Esteya\u00ae electronic brachytherapy system in non-melanoma skin cancers: A post-market observational study","volume":"16","author":"Cheng","year":"2024","journal-title":"J. Contemp. Brachyther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5114\/jcb.2023.125580","article-title":"Long-term clinical outcomes of non-melanoma skin cancer patients treated with electronic brachytherapy","volume":"15","author":"Doggett","year":"2023","journal-title":"J. Contemp. Brachyther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5114\/jcb.2021.109753","article-title":"Electronic brachytherapy for treatment of non-melanoma skin cancers: Clinical results and toxicities","volume":"13","author":"Goyal","year":"2021","journal-title":"J. Contemp. Brachyther."},{"key":"ref_113","first-page":"231","article-title":"Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma","volume":"7","author":"Barker","year":"2015","journal-title":"J. Contemp. Brachyther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.prro.2015.07.002","article-title":"Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer","volume":"5","author":"Paravati","year":"2015","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5732\/cjc.010.10529","article-title":"Proton therapy in clinical practice","volume":"30","author":"Liu","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Lane, S.A., Slater, J.M., and Yang, G.Y. (2023). Image-guided proton therapy: A comprehensive review. Cancers, 15.","DOI":"10.3390\/cancers15092555"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"285","DOI":"10.14338\/IJPT-20-00062.1","article-title":"Passively scattered proton therapy for nonmelanoma skin cancer with clinical perineural invasion","volume":"8","author":"Bryant","year":"2021","journal-title":"Int. J. Part. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Yacoub, I., Rayn, K., Choi, J.I., Bakst, R., Chhabra, A., Qian, J.Y., Johnstone, P., and Simone, C.B. (2024). The role of radiation, immunotherapy, and chemotherapy in the management of locally advanced or metastatic cutaneous malignancies. Cancers, 16.","DOI":"10.3390\/cancers16233920"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/07357907.2021.1944180","article-title":"Geospatial disparities in access to proton therapy in the continental United States","volume":"39","author":"Maillie","year":"2021","journal-title":"Cancer Investig."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s13555-023-00989-x","article-title":"Recommendations for cost-conscious treatment of basal cell carcinoma","volume":"13","author":"Patel","year":"2023","journal-title":"Dermatol. Ther."},{"key":"ref_121","unstructured":"International Atomic Energy Agency (2015). Implementation of High Dose Rate Brachytherapy in Limited Resource Settings, IAEA. Available online: https:\/\/www-pub.iaea.org\/MTCD\/Publications\/PDF\/Pub1670web-5444797.pdf."},{"key":"ref_122","unstructured":"Kharrati, K. (2024). Global Electronic Brachytherapy Market Size Likely to Reach at a CAGR of 9.48% by 2033, Custom Market Insights. Available online: https:\/\/www.custommarketinsights.com\/press-releases\/electronic-brachytherapy-market-size\/."},{"key":"ref_123","unstructured":"Particle Therapy Co-Operative Group (2025, September 09). Particle Therapy Facilities in Clinical Operation. Particle Therapy Co-Operative Group. Available online: https:\/\/www.ptcog.site\/index.php\/facilities-in-operation-public."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Helgadottir, H., J\u00f6nsson, G., Wickstr\u00f6m, S., Nilsson, J., Bj\u00f6rkstr\u00f6m, K., Berglund, A., Carneiro, A., Ny, L., and Olofsson Bagge, R. (2025). SWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4\/anti-PD-1 Blockade in Resectable Stage III Melanoma. Eur. J. Cancer Skin Cancer, 3.","DOI":"10.1016\/j.ejcskn.2025.100639"},{"key":"ref_125","first-page":"JCO2500759","article-title":"Phase II (Alliance A091802) randomized trial of avelumab plus cetuximab versus avelumab alone in advanced cutaneous squamous cell carcinoma","volume":"43","author":"Zandberg","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jaad.2024.06.023","article-title":"Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis","volume":"91","author":"Nardone","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_127","unstructured":"OncoBeta GmbH (2025, July 01). Rhenium-SCT\u00ae Skin Cancer Therapy. Freiburg, Germany. Available online: https:\/\/www.oncobeta.com\/our-products\/rhenium-sct."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Fukuda, H. (2021). Boron neutron capture therapy (BNCT) for cutaneous malignant melanoma using 10B-p-boronophenylalanine (BPA) with special reference to the radiobiological basis and clinical results. Cells, 10.","DOI":"10.3390\/cells10112881"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"110607","DOI":"10.1016\/j.radonc.2024.110607","article-title":"Boron neutron capture therapy for cutaneous angiosarcoma and malignant melanoma: First in-human phase I clinical trial","volume":"202","author":"Kashihara","year":"2025","journal-title":"Radiother. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1139\/cjp-2022-0266","article-title":"Boron neutron capture therapy in the new age of accelerator-based neutron production and preliminary progress in Canada","volume":"101","author":"Dziura","year":"2023","journal-title":"Can. J. Phys."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"096702","DOI":"10.1088\/0034-4885\/79\/9\/096702","article-title":"Nuclear physics in particle therapy: A review","volume":"79","author":"Durante","year":"2016","journal-title":"Rep. Prog. Phys."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0167-8140(04)80012-4","article-title":"Overview of clinical experiences on carbon ion radiotherapy at NIRS","volume":"73","author":"Tsujii","year":"2004","journal-title":"Radiother. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/bjs.1800720704","article-title":"Treatment of malignant melanoma by fast neutrons","volume":"72","author":"Blake","year":"1985","journal-title":"Br. J. Surg."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jrr\/rrad090","article-title":"Revolutionizing radiation therapy: The role of AI in clinical practice","volume":"65","author":"Kawamura","year":"2024","journal-title":"J. Radiat. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jid.2023.10.004","article-title":"Artificial intelligence in skin cancer diagnosis: A reality check","volume":"144","author":"Brancaccio","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41746-024-01161-1","article-title":"Learnings from the first AI-enabled skin cancer device for primary care authorized by FDA","volume":"7","author":"Venkatesh","year":"2024","journal-title":"NPJ Digit. Med."},{"key":"ref_137","unstructured":"University Hospitals of Liverpool NHS Foundation Trust (2024). Merseyside Hospital Pioneers the Use of AI Technology for Early Detection of Skin Cancer, University Hospitals of Liverpool NHS. Available online: https:\/\/www.uhliverpool.nhs.uk\/about-us\/our-stories\/merseyside-hospital-pioneers-use-ai-technology-early-detection-skin-cancer."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e230437","DOI":"10.1148\/ryai.230437","article-title":"Radiomics beyond the hype: A critical evaluation toward oncologic clinical use","volume":"6","author":"Horvat","year":"2024","journal-title":"Radiol. Artif. Intell."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6547\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:47:25Z","timestamp":1760035645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":138,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14186547"],"URL":"https:\/\/doi.org\/10.3390\/jcm14186547","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]}}}